The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.
July 11th 2025
Dalpiciclib combined with endocrine therapy significantly enhances progression-free survival in HR+/HER2– breast cancer, as shown in the DAWNA-A trial.
Statins May Reduce Mortality Risk in Prostate Cancer Patients
November 12th 2013Risk of death from prostate cancer was reduced for patients who started taking statins after being diagnosed with the disease and was reduced even more for those who started taking statins before being diagnosed.
Read More
Avella Specialty Pharmacy: Overcoming Oncology Adherence Barriers
June 18th 2013Specialty Pharmacy Times sat down to talk with Dr. Eric Sredzinski about the controversial topic of pricing for oncology medications, as well as common patient reimbursement hurdles and Avella's technologically savvy efforts to break down patient adherence barriers.
Read More
Welcome to our third annual special Oncology edition of Specialty Pharmacy Times! While new targeted oral medications are convenient and effective, they are also expensive and toxic, so the need for creating the greatest effectiveness from therapy is warranted. That's where specialty pharmacy comes in.
Read More